Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH 45229, USA.
Hum Genomics. 2013 Jul 5;7(1):16. doi: 10.1186/1479-7364-7-16.
The standard approach to determine unique or shared genetic factors across populations is to identify risk alleles in one population and investigate replication in others. However, since populations differ in DNA sequence information, allele frequencies, effect sizes, and linkage disequilibrium patterns, SNP association using a uniform stringent threshold on p values may not be reproducible across populations. Here, we developed rank-based methods to investigate shared or population-specific loci and pathways for childhood asthma across individuals of diverse ancestry. We performed genome-wide association studies on 859,790 SNPs genotyped in 527 affected offspring trios of European, African, and Hispanic ancestry using publically available asthma database in the Genotypes and Phenotypes database.
Rank-based analyses showed that there are shared genetic factors for asthma across populations, more at the gene and pathway levels than at the SNP level. Although the top 1,000 SNPs were not shared, 11 genes (RYR2, PDE4D, CSMD1, CDH13, ROBO2, RBFOX1, PTPRD, NPAS3, PDE1C, SEMA5A, and CTNNA2) mapped by these SNPs were shared across populations. Ryanodine receptor 2 (RYR2, a statin response-related gene) showed the strongest association in European (p value=2.55×10(-7)) and was replicated in African (2.57×10(-4)) and Hispanic (1.18 × 10(-3)) Americans. Imputation analyses based on the 1000 Genomes Project uncovered additional RYR2 variants associated with asthma. Network and functional ontology analyses revealed that RYR2 is an integral part of dermatological or allergic disorder biological networks, specifically in the functional classes involving inflammatory, eosinophilic, and respiratory diseases.
Our rank-based genome-wide analysis revealed for the first time an association of RYR2 variants with asthma and replicated previously discovered PDE4D asthma gene across human populations. The replication of top-ranked asthma genes across populations suggests that such loci are less likely to be false positives and could indicate true associations. Variants that are associated with asthma across populations could be used to identify individuals who are at high risk for asthma regardless of genetic ancestry.
确定不同人群中独特或共享遗传因素的标准方法是在一个人群中识别风险等位基因,并在其他人群中进行复制。然而,由于人群在 DNA 序列信息、等位基因频率、效应大小和连锁不平衡模式方面存在差异,因此使用统一的严格 p 值阈值进行 SNP 关联可能在不同人群中无法复制。在这里,我们开发了基于排名的方法来研究不同人群中儿童哮喘的共享或人群特异性基因座和途径。我们对来自欧洲、非洲和西班牙裔的 527 名受影响的后代三胞胎中 859790 个 SNP 进行了全基因组关联研究,这些 SNP 是使用 Genotypes and Phenotypes 数据库中公开的哮喘数据库进行基因分型的。
基于排名的分析表明,哮喘在人群中有共享的遗传因素,在基因和途径水平上比 SNP 水平上更多。虽然前 1000 个 SNP 不共享,但由这些 SNP 映射的 11 个基因(RYR2、PDE4D、CSMD1、CDH13、ROBO2、RBFOX1、PTPRD、NPAS3、PDE1C、SEMA5A 和 CTNNA2)在人群中共享。Ryanodine receptor 2(RYR2,他汀类药物反应相关基因)在欧洲(p 值=2.55×10(-7))表现出最强的相关性,在非洲(2.57×10(-4))和西班牙裔(1.18×10(-3))美国人中得到了复制。基于 1000 基因组计划的推测分析揭示了与哮喘相关的额外 RYR2 变体。网络和功能本体分析表明,RYR2 是皮肤或过敏疾病生物网络的重要组成部分,特别是在涉及炎症、嗜酸性粒细胞和呼吸疾病的功能类别中。
我们基于排名的全基因组分析首次揭示了 RYR2 变体与哮喘的关联,并在人类群体中复制了先前发现的 PDE4D 哮喘基因。在不同人群中复制排名靠前的哮喘基因表明,这些基因座不太可能是假阳性,可能表明存在真正的关联。与不同人群中的哮喘相关的变体可用于识别无论遗传背景如何都患有哮喘高风险的个体。